iBio,Β Inc. β Cash Flow Charts
63 quarters of history Β· ending 2025-12-31 Β· SEC EDGAR
Operating Cash Flowβ-52.5% -$2M
$-6M
Free Cash Flowβ-51500.0% -$515K
$-516K
Investing Cash Flowβ-3114.4% -$22M
$-21M
Financing Cash Flow
$9M
Capexβ+51500.0% +$515K
$516K
Acquisitions
$0
Stock-Based Compβ-46.7% -$222K
$253K
Debt Issued
$0
D&Aβ+15.6% +$19K
$141K
Ξ Working Capital
$365K